Grant Number:	1U01CA155340-01A1 Interpret this number
Primary Investigator:	Brennan, Paul
Organization:	International Agency For Res On Cancer
Project Title:	One-Carbon Metabolism Biomarkers and Lung Cancer Risk
Fiscal Year:	2011

DESCRIPTION (provided by applicant): We have recently identified strong associations between circulating biomarkers of one-carbon metabolism (OCM) and lung cancer within the European Prospective Investigation and Cancer (EPIC) cohort, based on prospectively collected blood samples from 900 cases and 1,800 controls. The study strongly implicated important protective effects for both vitamin B6 and methionine independently of smoking status, resulting in 2.5-fold risk differences between the top and bottom 25% of the population for these vitamin measures combined (p=10-12). Repeat measures indicated that these effects were substantially under-estimated because of regression dilution. The main objectives of this expanded study are two-fold: i) to clarify the role of B-vitamins and related factors (the one-carbon metabolism pathway) in lung cancer etiology in a study population large enough to allow robust risk analyses stratified by smoking status, using both molecular epidemiology and genetic approaches, and ii) to measure the role of OCM biomarkers in lung cancer risk prediction in multiple cohorts. We have initiated a lung cancer consortium in collaboration with over 20 cohorts participating in the NCI Cohort Consortium, including in total 11,500 prospectively collected lung cancer cases with blood samples. This study will include equal proportions of 1,200 never, former, and current smoking case-control pairs recruited in US/European/Australian cohorts, as well as 1,500 case-control pairs recruited in Asian cohorts. We will also include 1,000 repeat samples from a subgroup to allow for correction of regression dilution bias, resulting in biochemical analysis of 11,200 serum/plasma samples. Circulating levels of up to 40 biomarkers of one-carbon metabolism will be measured in the whole study population, and we will quantify their association with subsequent lung cancer risk. Important analyses of a priori interest will include measuring the association with risk among never and former smokers separately. These risk estimates will subsequently be used in risk prediction models, also taking regression dilution into account. Preliminary data from the EPIC cohort indicate that serum measures of methionine and vitamin B6 may identify up to 7-fold differences in life-time risk of lung cancer. Lung cancer remains a major health problem world-wide, and is responsible for 28% of all cancer deaths in the US. As well as elucidating the association between OCM biomarkers and lung cancer, this initiative will create more detailed risk prediction models, over and above that afforded by detailed information on tobacco exposure alone. The important work that will go into the construction of this consortium will also result in opportunities to initiate additional studies concerning lung cancer etiology. PUBLIC HEALTH RELEVANCE: In the US over 225,000 lung cancer cases are diagnosed every year representing approximately 15% of all new cancer cases, and 28% of cancer deaths. Although the main risk factor of lung cancer is tobacco exposure, nearly half of all lung cancer cases in the US occur among former and never smokers. We recently identified strong protective effects of elevated circulating levels of B- vitamins (in particular vitamin B6, folate, and also methionine) in a large cohort including pre-diagnostic blood samples in participants from eight European countries. The proposed study includes equal numbers of never, former and current smokers, aims to clarify a potentially strong beneficial role of B-vitamins and related factors in lung cancer development. The study will be conducted in collaboration with over 20 cohorts, and may identify important biomarkers for lung cancer risk prediction, over and above that afforded information on tobacco exposure.




Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults.
Authors: Zahed H. , Johansson M. , Ueland P.M. , Midttun Ø. , Milne R.L. , Giles G.G. , Manjer J. , Sandsveden M. , Langhammer A. , Sørgjerd E.P. , et al. .
Source: Scientific Reports, 2021-07-05 00:00:00.0; 11(1), p. 13805.
EPub date: 2021-07-05 00:00:00.0.
PMID: 34226613
Related Citations

Urinary Cotinine Is as Good a Biomarker as Serum Cotinine for Cigarette Smoking Exposure and Lung Cancer Risk Prediction.
Authors: Thomas C.E. , Wang R. , Adams-Haduch J. , Murphy S.E. , Ueland P.M. , Midttun Ø. , Brennan P. , Johansson M. , Gao Y.T. , Yuan J.M. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2020 01; 29(1), p. 127-132.
EPub date: 2019-11-04 00:00:00.0.
PMID: 31685561
Related Citations

Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Authors: Huang J.Y. , Larose T.L. , Luu H.N. , Wang R. , Fanidi A. , Alcala K. , Stevens V.L. , Weinstein S.J. , Albanes D. , Caporaso N.E. , et al. .
Source: International Journal Of Cancer, 2019-07-05 00:00:00.0; , .
EPub date: 2019-07-05 00:00:00.0.
PMID: 31276202
Related Citations

Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3).
Authors: Zuo H. , Ueland P.M. , Midttun Ø. , Tell G.S. , Fanidi A. , Zheng W. , Shu X. , Xiang Y. , Wu J. , Prentice R. , et al. .
Source: Annals Of Oncology : Official Journal Of The European Society For Medical Oncology, 2019-03-01 00:00:00.0; 30(3), p. 478-485.
PMID: 30698666
Related Citations

Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
Authors: Muller D.C. , Larose T.L. , Hodge A. , Guida F. , Langhammer A. , Grankvist K. , Meyer K. , Cai Q. , Arslan A.A. , Zeleniuch-Jacquotte A. , et al. .
Source: Bmj (clinical Research Ed.), 2019-01-03 00:00:00.0; 364, p. k4981.
EPub date: 2019-01-03 00:00:00.0.
PMID: 30606716
Related Citations

Is high vitamin B12 status a cause of lung cancer?
Authors: Fanidi A. , Carreras-Torres R. , Larose T.L. , Yuan J.M. , Stevens V.L. , Weinstein S.J. , Albanes D. , Prentice R. , Pettinger M. , Cai Q. , et al. .
Source: International Journal Of Cancer, 2018-11-29 00:00:00.0; , .
EPub date: 2018-11-29 00:00:00.0.
PMID: 30499135
Related Citations

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Authors: Larose T.L. , Guida F. , Fanidi A. , Langhammer A. , Kveem K. , Stevens V.L. , Jacobs E.J. , Smith-Warner S.A. , Giovannucci E. , Albanes D. , et al. .
Source: International Journal Of Epidemiology, 2018-06-12 00:00:00.0; , .
EPub date: 2018-06-12 00:00:00.0.
PMID: 29901778
Related Citations

No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
Authors: Muller D.C. , Hodge A.M. , Fanidi A. , Albanes D. , Mai X.M. , Shu X.O. , Weinstein S.J. , Larose T.L. , Zhang X. , Han J. , et al. .
Source: Annals Of Oncology : Official Journal Of The European Society For Medical Oncology, 2018-06-01 00:00:00.0; 29(6), p. 1468-1475.
PMID: 29617726
Related Citations

Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).
Authors: Fanidi A. , Muller D.C. , Yuan J.M. , Stevens V.L. , Weinstein S.J. , Albanes D. , Prentice R. , Thomsen C.A. , Pettinger M. , Cai Q. , et al. .
Source: Journal Of The National Cancer Institute, 2018-01-01 00:00:00.0; 110(1), .
PMID: 28922778
Related Citations

Impaired functional vitamin B6 status is associated with increased risk of lung cancer.
Authors: Theofylaktopoulou D. , Midttun Ø. , Ueland P.M. , Meyer K. , Fanidi A. , Zheng W. , Shu X.O. , Xiang Y.B. , Prentice R. , Pettinger M. , et al. .
Source: International Journal Of Cancer, 2017-12-14 00:00:00.0; , .
EPub date: 2017-12-14 00:00:00.0.
PMID: 29238985
Related Citations

Covariate measurement error correction methods in mediation analysis with failure time data.
Authors: Zhao S. , Prentice R.L. .
Source: Biometrics, 2014 Dec; 70(4), p. 835-44.
PMID: 25139469
Related Citations

Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients.
Authors: Midttun O. , Townsend M.K. , Nygård O. , Tworoger S.S. , Brennan P. , Johansson M. , Ueland P.M. .
Source: The Journal Of Nutrition, 2014 May; 144(5), p. 784-90.
PMID: 24647388
Related Citations